SCHEMBL12313248

SCHEMBL12313248

Cc1cc(C)cc(-c2ccc3cc(C)c(-n4cccc4)cc3n2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 1/20 0.36
▸ CYP19A1 P11511 1/20 0.35
▸ MAOA P21397 5/20 0.34
▸ MAOB P27338 5/20 0.34
▸ PDE10A Q9Y233 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ CYP2D6 P10635 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ AR P10275 1/20 0.31
▸ NPC1 O15118 2/20 0.30
▸ RAB9A P51151 2/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ ESR1 P03372 1/20 0.30
▸ ESR2 Q92731 1/20 0.30
▸ CASP3 P42574 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12313237 0.94 IGF1R (0.36) IGF1RCYP19A1MAOAMAOBPDE10A
SCHEMBL12313247 0.91 IGF1R (0.37) IGF1RCYP19A1MAOAMAOBKDM4E
SCHEMBL12313249 0.89 RAB9A (0.41) IGF1RMAOAMAOBKDM4EALDH1A1
SCHEMBL12313243 0.84 NPC1 (0.44) IGF1RCYP19A1MAOAMAOBKDM4E
SCHEMBL12313242 0.84 PDE10A (0.39) PDE10A
SCHEMBL12313235 0.83 RAB9A (0.41) IGF1RMAOAMAOBKDM4EALDH1A1
SCHEMBL12313246 0.80 RAB9A (0.43) IGF1RMAOAMAOBKDM4EALDH1A1
SCHEMBL13870794 0.80 NPC1 (0.40) PDE10AKDM4ECYP1A2ALDH1A1TDP1
SCHEMBL12313231 0.79 PDE10A (0.38) PDE10AKDM4E
SCHEMBL12313221 0.79 MAOA (0.41) IGF1RMAOAMAOBKDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263237-B2 Red phosphorescent composition and organic electroluminescent device using the same LG DISPLAY CO., LTD (KR) 2012-09-11 — — US disclosed
US-8263237-B2 Red phosphorescent composition and organic electroluminescent device using the same LG DISPLAY CO., LTD (KR) 2012-09-11 — — US disclosed
US-20100102714-A1 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2010-04-29 — — US disclosed
US-20100102714-A1 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2010-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100102714-A1 Red phosphorescent compound and organic electroluminescent device using the same YTHDC1, IK, PYCR1 IGF1R 1399/4885CYP19A1 2541/4885MAOA 3569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback